{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:34:37Z","timestamp":1774942477187,"version":"3.50.1"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00005-022-00650-z","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T22:03:52Z","timestamp":1648159432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic"],"prefix":"10.2478","volume":"70","author":[{"given":"Ma\u0142gorzata","family":"Jerzak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-6822","authenticated-orcid":false,"given":"Monika","family":"Szafarowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"650_CR1","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3389\/fphar.2020.01062","volume":"11","author":"J Acosta-Elias","year":"2020","unstructured":"Acosta-Elias J, Espinosa-Tanguma R (2020) The folate concentration and\/or folic acid metabolites in plasma as factor for COVID-19 infection. Front Pharmacol 11:1062","journal-title":"Front Pharmacol"},{"key":"650_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijms22062872","volume":"22","author":"AJH Albaghdadi","year":"2021","unstructured":"Albaghdadi AJH, Kan FWK (2021) Therapeutic potentials of low-dose tacrolimus for aberrant endometrial features in polycystic ovary syndrome. Int J Mol Sci 22:6","journal-title":"Int J Mol Sci"},{"key":"650_CR3","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1038\/s41598-019-42960-x","volume":"9","author":"AJH Albaghdadi","year":"2019","unstructured":"Albaghdadi AJH, Feeley CA, Kan FWK (2019) Low-dose tacrolimus prevents dysregulated peri-conceptional ovarian and systemic immune cellular homeostasis in subjects with PCOS. Sci Rep 9:6528","journal-title":"Sci Rep"},{"key":"650_CR4","first-page":"95","volume":"22","author":"F Ciceri","year":"2020","unstructured":"Ciceri F, Beretta L, Scandroglio AM et al (2020) Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc 22:95\u201397","journal-title":"Crit Care Resusc"},{"key":"650_CR5","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2020006000","volume":"135","author":"JM Connors","year":"2020","unstructured":"Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood 135:2033\u20132040","journal-title":"Blood"},{"key":"650_CR6","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.15585\/mmwr.mm6938e1","volume":"69","author":"MJ Delahoy","year":"2020","unstructured":"Delahoy MJ, Whitaker M, O\u2019Halloran A et al (2020) Characteristics and Maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep 69:1347\u20131354","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"650_CR7","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.15585\/mmwr.mm7047e1","volume":"70","author":"CL DeSisto","year":"2021","unstructured":"DeSisto CL, Wallace B, Simeone R et al (2021) Risk for stillbirth among women with and without COVID-19 at delivery hospitalization: United States, March 2020\u2013September 2021. Morb Mortal Wkl Rep 70:1640\u20131645","journal-title":"Morb Mortal Wkl Rep"},{"key":"650_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jinf.2020.03.041","volume":"80","author":"L Fu","year":"2020","unstructured":"Fu L, Wang B, Yuan T et al (2020) Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect 80:656\u2013665","journal-title":"J Infect"},{"key":"650_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12863-015-0165-4","volume":"16","author":"R Guo","year":"2015","unstructured":"Guo R, Zheng Y, Yang J et al (2015) Association of TNF-alpha, IL-6 and IL-1beta gene polymorphisms with polycystic ovary syndrome: a meta-analysis. BMC Genet 16:5","journal-title":"BMC Genet"},{"key":"650_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijms19071954","volume":"19","author":"S Hyer","year":"2018","unstructured":"Hyer S, Balani J, Shehata H (2018) Metformin in pregnancy: mechanisms and clinical applications. Int J Mol Sci 19:7","journal-title":"Int J Mol Sci"},{"key":"650_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12325-019-01124-z","volume":"37","author":"B Jacobson","year":"2020","unstructured":"Jacobson B, Rambiritch V, Paek D et al (2020) Safety and efficacy of enoxaparin in pregnancy: a systematic review and meta-analysis. Adv Ther 37:27\u201340","journal-title":"Adv Ther"},{"key":"650_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","volume":"8","author":"JM Jin","year":"2020","unstructured":"Jin JM, Bai P, He W et al (2020) Gender differences in patients with COVID-19: Focus on severity and mortality. Front Public Health 8:152","journal-title":"Front Public Health"},{"key":"650_CR13","doi-asserted-by":"publisher","first-page":"103168","DOI":"10.1016\/j.jri.2020.103168","volume":"141","author":"J Kwak-Kim","year":"2020","unstructured":"Kwak-Kim J, Ota K, Sung N et al (2020) COVID-19 and immunomodulation treatment for women with reproductive failures. J Reprod Immunol 141:103168","journal-title":"J Reprod Immunol"},{"key":"650_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12916-020-01697-5","volume":"18","author":"I Kyrou","year":"2020","unstructured":"Kyrou I, Karteris E, Robbins T et al (2020) Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med 18:220","journal-title":"BMC Med"},{"key":"650_CR15","doi-asserted-by":"publisher","first-page":"e13340","DOI":"10.1111\/aji.13340","volume":"84","author":"W Li","year":"2020","unstructured":"Li W, Yu N, Kang Q et al (2020) Clinical manifestations and maternal and perinatal outcomes with COVID-19. Am J Reprod Immunol 84:e13340","journal-title":"Am J Reprod Immunol"},{"key":"650_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10815-013-0171-2","volume":"31","author":"Y Liu","year":"2014","unstructured":"Liu Y, Sun MG, Jiang R et al (2014) Plasminogen activator inhibitor-1 -675 4G\/5G polymorphism and polycystic ovary syndrome risk: a meta-analysis. J Assist Reprod Genet 31:363\u2013370","journal-title":"J Assist Reprod Genet"},{"key":"650_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4269\/ajtmh.20-0375","volume":"103","author":"P Luo","year":"2020","unstructured":"Luo P, Qiu L, Liu Y et al (2020) Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis. Am J Trop Med Hyg 103:69\u201372","journal-title":"Am J Trop Med Hyg"},{"key":"650_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/aji.12493","volume":"76","author":"A Mekinian","year":"2016","unstructured":"Mekinian A, Cohen J, Alijotas-Reig J et al (2016) Unexplained recurrent miscarriage and recurrent implantation failure: is there a place for immunomodulation? Am J Reprod Immunol 76:8\u201328","journal-title":"Am J Reprod Immunol"},{"key":"650_CR19","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.dsx.2020.10.014","volume":"14","author":"F Moradi","year":"2020","unstructured":"Moradi F, Enjezab B, Ghadiri-Anari A (2020) The role of androgens in COVID-19. Diabetes Metab Syndr 14:2003\u20132006","journal-title":"Diabetes Metab Syndr"},{"key":"650_CR20","doi-asserted-by":"publisher","first-page":"105770","DOI":"10.1016\/j.jsbmb.2020.105770","volume":"205","author":"G Morgante","year":"2021","unstructured":"Morgante G, Troia L, De Leo V (2021) Coronavirus disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women? J Steroid Biochem Mol Biol 205:105770","journal-title":"J Steroid Biochem Mol Biol"},{"key":"650_CR21","doi-asserted-by":"publisher","first-page":"e13304","DOI":"10.1111\/aji.13304","volume":"84","author":"KP Muyayalo","year":"2020","unstructured":"Muyayalo KP, Huang DH, Zhao SJ et al (2020) COVID-19 and Treg\/Th17 imbalance: Potential relationship to pregnancy outcomes. Am J Reprod Immunol 84:e13304","journal-title":"Am J Reprod Immunol"},{"key":"650_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/aji.12338","volume":"73","author":"K Nakagawa","year":"2015","unstructured":"Nakagawa K, Kwak-Kim J, Ota K et al (2015) Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1\/TH2 cell ratios. Am J Reprod Immunol 73:353\u2013361","journal-title":"Am J Reprod Immunol"},{"key":"650_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.18773\/austprescr.2019.026","volume":"42","author":"K Paizis","year":"2019","unstructured":"Paizis K (2019) Immunomodulatory drugs in pregnancy and lactation. Aust Prescr 42:97\u2013101","journal-title":"Aust Prescr"},{"key":"650_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.fertnstert.2005.04.021","volume":"84","author":"S Palomba","year":"2005","unstructured":"Palomba S, Orio F Jr, Falbo A et al (2005) Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome. Fertil Steril 84:761\u2013765","journal-title":"Fertil Steril"},{"key":"650_CR25","doi-asserted-by":"publisher","first-page":"109859","DOI":"10.1016\/j.mehy.2020.109859","volume":"143","author":"G Ponti","year":"2020","unstructured":"Ponti G, Ruini C, Tomasi A (2020) Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19. Med Hypotheses 143:109859","journal-title":"Med Hypotheses"},{"key":"650_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","volume":"98","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2012","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2012) Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 98:1103\u20131111","journal-title":"Fertil Steril"},{"key":"650_CR27","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 323:2052\u20132059","journal-title":"JAMA"},{"key":"650_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325","journal-title":"Fertil Steril"},{"key":"650_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF et al (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 110:364\u2013379","journal-title":"Fertil Steril"},{"key":"650_CR30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0026-0495(97)90066-4","volume":"46","author":"EM Velazquez","year":"1997","unstructured":"Velazquez EM, Mendoza SG, Wang P et al (1997) Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism 46:454\u2013457","journal-title":"Metabolism"},{"key":"650_CR31","doi-asserted-by":"publisher","first-page":"e13081","DOI":"10.1111\/aji.13081","volume":"81","author":"P Verma","year":"2019","unstructured":"Verma P, Verma R, Nair RR et al (2019) Altered crosstalk of estradiol and progesterone with Myeloid-derived suppressor cells and Th1\/Th2 cytokines in early miscarriage is associated with early breakdown of maternal-fetal tolerance. Am J Reprod Immunol 81:e13081","journal-title":"Am J Reprod Immunol"},{"key":"650_CR32","doi-asserted-by":"publisher","first-page":"e13097","DOI":"10.1111\/aji.13097","volume":"81","author":"K Yamaguchi","year":"2019","unstructured":"Yamaguchi K (2019) Tacrolimus treatment for infertility related to maternal-fetal immune interactions. Am J Reprod Immunol 81:e13097","journal-title":"Am J Reprod Immunol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-022-00650-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00005-022-00650-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-022-00650-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:48Z","timestamp":1704228588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00005-022-00650-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1007\/s00005-022-00650-z","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"23 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interests regarding the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study design was approved by the Institutional Review Board of the Military Institute of Medicine in Warsaw.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"13"}}